Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Long-Term Debt Issuances (2020 - 2021)

Historic Long-Term Debt Issuances for Janux Therapeutics (JANX) over the last 2 years, with Q2 2021 value amounting to $68.8 million.

  • Janux Therapeutics' Long-Term Debt Issuances changed N/A to $68.8 million in Q2 2021 from the same period last year, while for Mar 2022 it was $68.8 million, marking a year-over-year change of. This contributed to the annual value of $124.8 million for FY2021, which is 129406.97% up from last year.
  • Latest data reveals that Janux Therapeutics reported Long-Term Debt Issuances of $68.8 million as of Q2 2021.
  • Over the past 5 years, Janux Therapeutics' Long-Term Debt Issuances peaked at $68.8 million during Q2 2021, and registered a low of -$33000.0 during Q3 2020.